Latest & greatest articles for screening

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on screening or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for screening

101. Breast screening: Fujifilm Amulet Innovality DBT system evaluation

Breast screening: Fujifilm Amulet Innovality DBT system evaluation Breast screening: Fujifilm Amulet Innovality DBT system evaluation - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Breast screening: Fujifilm (...) Amulet Innovality DBT system evaluation Practical evaluation of the Fujifilm Amulet Innovality digital breast tomosynthesis system used in the NHS breast screening programme. Published 9 December 2019 Last updated 9 December 2019 — From: Documents Ref: PHE publications gateway number GW-935 9 December 2019 Updated the executive summary on page 4. 9 December 2019 First published. Related content Collection Explore the topic Is this page useful? Thank you for your feedback Help us improve GOV.UK Don’t

2019 Public Health England

102. Helping physicians fatigued by TSH Screening and Subclinical Hypothyroidism

Helping physicians fatigued by TSH Screening and Subclinical Hypothyroidism Tools for Practice is proudly sponsored by the Alberta College of Family Physicians (ACFP). ACFP is a provincial, professional voluntary organization, representing more than 4,800 family physicians, family medicine residents, and medical students in Alberta. Established over sixty years ago, the ACFP strives for excellence in family practice through advocacy, continuing medical education and primary care research (...) . www.acfp.ca December 9, 2019 (en français) Helping physicians fatigued by TSH Screening and Subclinical Hypothyroidism Clinical Question: Is there evidence for screening for thyroid function or treating subclinical hypothyroidism? Bottom Line: There is no randomized controlled trial (RCT) of screening for thyroid function [ordering thyroid stimulating hormone (TSH) in non-pregnant healthy people]. Despite approximately 20 RCTs, there are no patient-oriented benefits (like preventing cardiovascular disease

2019 Tools for Practice

103. Breast screening: Hologic 3Dimensions in 2D mode

Breast screening: Hologic 3Dimensions in 2D mode Breast screening: Hologic 3Dimensions in 2D mode - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Breast screening: Hologic 3Dimensions in 2D mode Practical (...) evaluation of the Hologic 3Dimensions digital mammography system in 2D mode. Published 9 December 2019 From: Documents Ref: PHE publications gateway number GW-934 If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. Details This document presents a practical evaluation of the Hologic 3Dimensions digital mammography system

2019 Public Health England

104. Cervical screening: programme overview

Cervical screening: programme overview Cervical screening: programme overview - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Cervical screening: programme overview A description of the NHS cervical screening (...) programme, including evidence on screening and the human papillomavirus (HPV). Published 1 April 2015 Last updated 18 November 2019 — From: Contents is the process of identifying individuals who appear healthy but may be at increased risk of a disease or condition. The process is not perfect and in every screen there are a number of false positive and false negative results. NHS cervical screening programme is available to women and people with a cervix aged 25 to 64 in England. All eligible people who

2019 Public Health England

105. Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines

Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines - Crow - 2019 - Transplant International - Wiley Online Library By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term Original (...) Article Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines Department of Dermatology, University of California San Francisco, San Francisco, CA, USA Division of Dermatology, Dell Medical School, University of Texas at Austin, Austin, TX, USA Montgomery Dermatology/Lankenau Institute for Medical Research, King of Prussia, PA, USA Advanced Heart Failure Center, Sentara Heart Hospital, Norfolk, VA, USA

2019 International Society for Heart and Lung Transplantation

106. Screening and Management of the Hyperandrogenic Adolescent

Screening and Management of the Hyperandrogenic Adolescent ACOGCOMMITTEEOPINION Number 789 Committee on Adolescent Health Care This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Adolescent Health Care in collaboration with committee members Jennie Yoost, MD and Ashlyn Savage, MD. Screening and Management of the Hyperandrogenic Adolescent ABSTRACT: Although androgen excess can manifest in many ways, the most common and recognizable (...) of PCOS and those of normal puberty,whichmakesthediagnosisofPCOSintheadolescentdifficult.Treatmentofacneandhirsutismshould not be withheld during the ongoing longitudinal evaluation for possible PCOS. On physical examination, body mass index, blood pressure, and signs of hyperandrogenism, such as acne and hirsutism, should be evaluated. Although guidelines differ on recommended laboratory studies, most include measurement of total testoster- one, free testosterone, or both, and screening

2019 American College of Obstetricians and Gynecologists

107. The screening and management of newborns at risk for low blood glucose

The screening and management of newborns at risk for low blood glucose Hypoglycemia in the first hours to days after birth remains one of the most common conditions facing practitioners across Canada who care for newborns. Many cases represent normal physiologic transition to extrauterine life, but another group experiences hypoglycemia of longer duration. This statement addresses key issues for providers of neonatal care, including the definition of hypoglycemia, risk factors, screening (...) protocols, blood glucose levels requiring intervention, and managing care for this condition. Screening, monitoring, and intervention protocols have been revised to better identify, manage, and treat infants who are at risk for persistent, recurrent, or severe hypoglycemia. The role of dextrose gels in raising glucose levels or preventing more persistent hypoglycemia, and precautions to reduce risk for recurrence after leaving hospital, are also addressed. This statement differentiates between

2019 Canadian Paediatric Society

108. Recommendation on screening adults for asymptomatic thyroid dysfunction in primary care

Recommendation on screening adults for asymptomatic thyroid dysfunction in primary care Recommendation on screening adults for asymptomatic thyroid dysfunction in primary care | CMAJ Main menu User menu Search Search for this keyword Search for this keyword Guideline Recommendation on screening adults for asymptomatic thyroid dysfunction in primary care Richard Birtwhistle , Kate Morissette , James A. Dickinson , Donna L. Reynolds , Marc T. Avey , Francesca Reyes Domingo , Rachel Rodin (...) of Family Medicine and Community Health Sciences (Dickinson), University of Calgary, Alta.; Dalla Lana School of Public Health and Department of Family and Community Medicine (Reynolds), University of Toronto, Ont.; Department of Psychiatry (Thombs), Jewish General Hospital and McGill University, Montréal, Que. KEY POINTS The Canadian Task Force on Preventive Health Care strongly recommends against screening for thyroid dysfunction in asymptomatic nonpregnant adults. Screening for thyroid dysfunction

2019 Canadian Task Force on Preventive Health Care

109. Summary of Cervical Cancer Screening Recommendations for Non-HIV Immunocompromised Women

Summary of Cervical Cancer Screening Recommendations for Non-HIV Immunocompromised Women (current immunosuppressants are listed in Table 2). Women with RA and IBD not on immunosuppressants and women with DM were considered at no increased risk compared with the general population. Screening recommendations based on these risks are summarizedinTable3. REFERENCES 1. GrulichAE,vanLeeuwenMT,FalsterMO,etal.Incidence ofcancersin peoplewithHIV/AIDScomparedwithimmunosuppressedtransplant recipients (...) . If resultofcytologyisnormalandHPVisnegative,co-testingcanbe performedevery 3 y -Iftransplantbefore theage of21y, begin screening within1 yofsexualdebut -Continue screeningthroughout lifetime (older than 65y). Discontinue screeningbasedonshareddiscussionregardingqualityand durationoflife rather thanage -Screenpatientsondialysis and posttransplantsimilarly Allogeneichematopoietic stem cell transplant -Cytologyisrecommendedifyounger than 30y -Co-testingispreferred, but cytologyisacceptableif 30yorolder -Ifusing cytologyalone, perform

2019 American Society for Clinical Pathology

110. Sequential screening for lung cancer in a high-risk group: randomised controlled trial: LungSEARCH: a randomised controlled trial of Surveillance using sputum and imaging for the EARly detection of lung Cancer in a High-risk group Full Text available with Trip Pro

Sequential screening for lung cancer in a high-risk group: randomised controlled trial: LungSEARCH: a randomised controlled trial of Surveillance using sputum and imaging for the EARly detection of lung Cancer in a High-risk group Low-dose computed tomography (LDCT) screening detects early-stage lung cancer and reduces mortality. We proposed a sequential approach targeted to a high-risk group as a potentially efficient screening strategy.LungSEARCH was a national multicentre randomised trial (...) . Current/ex-smokers with mild/moderate chronic obstructive pulmonary disease (COPD) were allocated (1:1) to have 5 years surveillance or not. Screened participants provided annual sputum samples for cytology and cytometry, and if abnormal were offered annual LDCT and autofluorescence bronchoscopy (AFB). Those with normal sputum provided annual samples. The primary end-point was the percentage of lung cancers diagnosed at stage I/II (nonsmall cell) or limited disease (small cell).1568 participants were

2019 EvidenceUpdates

111. Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment: A Randomized Clinical Trial Full Text available with Trip Pro

Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment: A Randomized Clinical Trial In the United States, more than 50% of cervical cancers are diagnosed in underscreened women. Cervical cancer screening guidelines now include primary human papillomavirus (HPV) testing as a recommended strategy. Home-based HPV self-sampling is a viable option for increasing screening compliance and effectiveness; however (...) , US data are needed to inform health care system implementation.To evaluate effectiveness of mailed HPV self-sampling kits vs usual care reminders for in-clinic screening to increase detection and treatment of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) and uptake of cervical cancer screening.Randomized clinical trial conducted in Kaiser Permanente Washington, a US integrated health care delivery system. Women aged 30 to 64 years with health plan enrollment for 3 years and 5 months

2019 EvidenceUpdates

112. Supplemental MRI Screening for Women with Extremely Dense Breast Tissue. Full Text available with Trip Pro

Supplemental MRI Screening for Women with Extremely Dense Breast Tissue. Extremely dense breast tissue is a risk factor for breast cancer and limits the detection of cancer with mammography. Data are needed on the use of supplemental magnetic resonance imaging (MRI) to improve early detection and reduce interval breast cancers in such patients.In this multicenter, randomized, controlled trial in the Netherlands, we assigned 40,373 women between the ages of 50 and 75 years with extremely dense (...) breast tissue and normal results on screening mammography to a group that was invited to undergo supplemental MRI or to a group that received mammography screening only. The groups were assigned in a 1:4 ratio, with 8061 in the MRI-invitation group and 32,312 in the mammography-only group. The primary outcome was the between-group difference in the incidence of interval cancers during a 2-year screening period.The interval-cancer rate was 2.5 per 1000 screenings in the MRI-invitation group and 5.0

2019 NEJM

113. Life-Gained-Based Versus Risk-Based Selection of Smokers for Lung Cancer Screening. Full Text available with Trip Pro

Life-Gained-Based Versus Risk-Based Selection of Smokers for Lung Cancer Screening. Although risk-based selection of ever-smokers for screening could prevent more lung cancer deaths than screening according to the U.S. Preventive Services Task Force (USPSTF) guidelines, it preferentially selects older ever-smokers with shorter life expectancies due to comorbidities.To compare selection of ever-smokers for screening based on gains in life expectancy versus lung cancer risk.Cohort analyses (...) and model-based projections.U.S. population of ever-smokers aged 40 to 84 years.130 964 National Health Interview Survey participants, representing about 60 million U.S. ever-smokers during 1997 to 2015.Annual computed tomography (CT) screening for 3 years versus no screening.Estimated number of lung cancer deaths averted and life-years gained after development of a mortality model.Using the calibrated and validated mortality model in U.S. ever-smokers aged 40 to 84 years and selecting 8.3 million ever

2019 Annals of Internal Medicine

114. Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians. Full Text available with Trip Pro

Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians. The purpose of this guidance statement is to guide clinicians on colorectal cancer screening in average-risk adults.This guidance statement is derived from a critical appraisal of guidelines on screening for colorectal cancer in average-risk adults and the evidence presented in these guidelines. National guidelines published in English between 1 June 2014 and 28 May (...) should screen for colorectal cancer in average-risk adults between the ages of 50 and 75 years.Clinicians should select the colorectal cancer screening test with the patient on the basis of a discussion of benefits, harms, costs, availability, frequency, and patient preferences. Suggested screening tests and intervals are fecal immunochemical testing or high-sensitivity guaiac-based fecal occult blood testing every 2 years, colonoscopy every 10 years, or flexible sigmoidoscopy every 10 years plus

2019 Annals of Internal Medicine

115. Newborn hearing screening programme (NHSP) operational guidance

Newborn hearing screening programme (NHSP) operational guidance Newborn hearing screening programme (NHSP) operational guidance - GOV.UK GOV.UK uses cookies to make the site simpler. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Newborn hearing screening programme (NHSP) operational guidance This guidance supports healthcare professionals and stakeholders delivering and managing newborn hearing screening programmes in England. Published 1 November 2016 (...) Last updated 16 July 2019 — From: Documents HTML HTML HTML HTML HTML HTML HTML HTML HTML HTML HTML https://www.gov.uk/government/publications/newborn-hearing-screening-equipment-log-sheets If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. MS Word Document , 23.9KB This file may not be suitable for users

2019 Public Health England

116. Cervical screening: histopathology reporting handbook

Cervical screening: histopathology reporting handbook Cervical screening: histopathology reporting handbook - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Register by 26 November to vote in the General Election on 12 (...) December. Guidance Cervical screening: histopathology reporting handbook This document explains procedures for the reporting of cervical biopsies in the NHS cervical screening programme. Published 1 September 2012 Last updated 15 November 2019 — From: Documents HTML If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use

2019 Public Health England

117. Fetal anomaly screening: ultrasound practitioners handbook

Fetal anomaly screening: ultrasound practitioners handbook Fetal anomaly screening: ultrasound practitioners handbook - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Register by 26 November to vote in the General (...) Election on 12 December. Guidance Fetal anomaly screening: ultrasound practitioners handbook This document sets out ultrasound guidelines and recommendations for the NHS fetal anomaly screening programme (FASP). Published 1 January 2015 Last updated 29 October 2019 — From: Documents Ref: 2015002 If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what

2019 Public Health England

118. Bowel cancer screening: imaging use

Bowel cancer screening: imaging use Bowel cancer screening: imaging use - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Register by 26 November to vote in the General Election on 12 December. Guidance Bowel cancer (...) screening: imaging use Information about imaging practice standards for bowel cancer screening of individuals unsuitable for a colonoscopy. Published 1 November 2012 Last updated 14 October 2019 — From: Documents Ref: PHE publications gateway number: GW-810 HTML Details This publication explains the use of whole colon imaging as an alternative to a colonoscopy as part of the NHS Bowel Cancer Screening Programme ( 14 October 2019 Added new guidelines on CTC imaging in NHS bowel cancer screening. 1

2019 Public Health England

119. Assessing the Accuracy of Machine-Assisted Abstract Screening With DistillerAI: A User Study

Assessing the Accuracy of Machine-Assisted Abstract Screening With DistillerAI: A User Study Methods Research Report Assessing the Accuracy of Machine-Assisted Abstract Screening With DistillerAI: A User Study Methods Research Report Assessing the Accuracy of Machine-Assisted Abstract Screening With DistillerAI: A User Study Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 290 (...) 3 Department of Family Medicine, Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands AHRQ Publication No. 19(20)-EHC026 -EF November 2019 ii Key Messages Purpose of the report This report summarizes a methods study that evaluated the accuracy of a machine-assisted abstract screening approach that temporarily replaced a human screener with a semi-automated screening tool. Key messages • Results of our study rendered a mean sensitivity of 78 percent

2019 Effective Health Care Program (AHRQ)

120. Effect of Depression Screening After Acute Coronary Syndromes on Quality of Life: The CODIACS-QoL Randomized Clinical Trial (Abstract)

Effect of Depression Screening After Acute Coronary Syndromes on Quality of Life: The CODIACS-QoL Randomized Clinical Trial Patients with acute coronary syndrome (ACS) and elevated depressive symptoms are at increased risk for recurrent cardiovascular events and mortality, worse quality of life, and higher health care costs. These observational findings prompted multiple scientific panels to advise universal depression screening in survivors of ACS prior to evidence from randomized screening (...) trials.To determine whether systematically screening for depression in survivors of ACS improves quality of life and depression compared with usual care.A 3-group multisite randomized trial enrolled 1500 patients with ACS from 4 health care systems between November 1, 2013, and March 31, 2017, with follow-up ending July 31, 2018. Patients were eligible if they had been hospitalized for ACS in the previous 2 to 12 months and had no prior history of depression. All analyses were performed on an intention

2019 EvidenceUpdates